Antifungal mechanism of FK463 against Candida albicans and Aspergillus fumigatus

被引：62

作者：

Hatano, K ^{[1
]}

Morishita, Y ^{[1
]}

Nakai, T ^{[1
]}

Ikeda, F ^{[1
]}

机构：

[1] Fujisawa Pharmaceut Co Ltd, Med Biol Res Labs, Yodogawa Ku, Osaka 5328514, Japan

来源：

JOURNAL OF ANTIBIOTICS | 2002年 / 55卷 / 02期

关键词：

D O I：

10.7164/antibiotics.55.219

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

[No abstract available]

引用

收藏

页码：219 / 222

页数：4

相关论文

共 13 条

[11] W-1 SOLUBILIZATION AND KINETICS OF INHIBITION BY CILOFUNGIN OF CANDIDA-ALBICANS (1,3)-BETA-D-GLUCAN SYNTHASE
TANG, J
PARR, TR
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (01) : 99 - 103
[12] In vitro activities of a new lipopeptide antifungal agent, FK463, against a variety of clinically important fungi
Tawara, S
Ikeda, F
Maki, K
Morishita, Y
Otomo, K
Teratani, N
Goto, T
Tomishima, M
Ohki, H
Yamada, A
Kawabata, K
Takasugi, H
Sakane, K
Tanaka, H
Matsumo, F
Kuwahara, S
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (01) : 57 - 62
[13] Wade James C., 1997, Leukemia (Basingstoke), V11, pS38